LivaNova Insider Trades
NASDAQ: LIVNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 7 · $1.05M
- Shares bought / sold
- 0 / 13.38K
- Net activity
- Net selling $1.0 million
LivaNova insider activity
Over the last 12 months, LivaNova insiders reported 51 transactions on SEC Form 4: 0 open-market purchases and 7 sales. Insiders bought $0 and sold $1.0 million worth of stock, for net insider selling of $1.0 million. The largest seller was Bianchi Francesco, with $637,148 in reported sales.
The most recent filing shows Bianchi Francesco (Director) selling 3,500 shares at $78.01 on Sep 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LIVN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LIVN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 10, 2026 | Bianchi FrancescoDirector | Sale | 3,500 | $273.03K | Form 4 |
| Sep 4, 2026 | Story BrookeDirector | Sale | 2,300 | $187.27K | Form 4 |
| Aug 31, 2026 | Bianchi FrancescoDirector | Sale | 1,650 | $131.54K | Form 4 |
| Aug 11, 2026 | Tezel AhmetChief Innovation Officer | Sale | 2,675 | $207.94K | Form 4 |
| Aug 11, 2026 | Tezel AhmetChief Innovation Officer | Tax withholding | 1,428 | $111.18K | Form 4 |
| Aug 11, 2026 | Tezel AhmetChief Innovation Officer | Disposition | 8,589 | $668.74K | Form 4 |
| Aug 11, 2026 | Tezel AhmetChief Innovation Officer | Option exercise | 12,692 | $668.61K | Form 4 |
| Jun 15, 2026 | Zurbay DonaldDirector | Tax withholding | 308 | $24.55K | Form 4 |
| Jun 15, 2026 | Zurbay DonaldDirector | Option exercise | 2,560 | — | Form 4 |
| Jun 15, 2026 | Story BrookeDirector | Tax withholding | 486 | $38.73K | Form 4 |
| Jun 15, 2026 | Story BrookeDirector | Option exercise | 4,042 | — | Form 4 |
| Jun 15, 2026 | Bianchi FrancescoDirector | Sale | 1,200 | $96.23K | Form 4 |
| Jun 15, 2026 | Bianchi FrancescoDirector | Tax withholding | 486 | $38.73K | Form 4 |
| Jun 15, 2026 | Bianchi FrancescoDirector | Option exercise | 4,042 | — | Form 4 |
| Jun 15, 2026 | Tezel AhmetChief Innovation Officer | Tax withholding | 1,032 | $82.25K | Form 4 |
| Jun 15, 2026 | Tezel AhmetChief Innovation Officer | Option exercise | 2,965 | — | Form 4 |
| Jun 15, 2026 | PODLOGAR SUSAN MDirector | Tax withholding | 486 | $38.73K | Form 4 |
| Jun 15, 2026 | PODLOGAR SUSAN MDirector | Option exercise | 4,042 | — | Form 4 |
| Jun 15, 2026 | Enxing Seng StacyDirector | Tax withholding | 486 | $38.73K | Form 4 |
| Jun 15, 2026 | Enxing Seng StacyDirector | Option exercise | 4,042 | — | Form 4 |
| Jun 15, 2026 | KOZY WILLIAM ADirector | Tax withholding | 682 | $54.36K | Form 4 |
| Jun 15, 2026 | KOZY WILLIAM ADirector | Option exercise | 5,681 | — | Form 4 |
| Jun 15, 2026 | SCHERMERHORN TODD CDirector | Tax withholding | 486 | $38.73K | Form 4 |
| Jun 15, 2026 | SCHERMERHORN TODD CDirector | Option exercise | 4,042 | — | Form 4 |
| Jun 15, 2026 | Barry James ChristopherDirector | Tax withholding | 486 | $38.73K | Form 4 |
| Jun 15, 2026 | Barry James ChristopherDirector | Option exercise | 4,042 | — | Form 4 |
| Jun 15, 2026 | WILVER PETER MDirector | Tax withholding | 486 | $38.73K | Form 4 |
| Jun 15, 2026 | WILVER PETER MDirector | Option exercise | 4,042 | — | Form 4 |
| May 26, 2026 | Bianchi FrancescoDirector | Sale | 1,800 | $136.35K | Form 4 |
| Mar 30, 2026 | Kozmina NataliaChief Human Resources Officer | Tax withholding | 1,374 | $84.18K | Form 4 |
| Mar 30, 2026 | Kozmina NataliaChief Human Resources Officer | Option exercise | 6,389 | — | Form 4 |
| Mar 30, 2026 | Bolton StephaniePresident, Global Epilepsy | Tax withholding | 8,377 | $513.26K | Form 4 |
| Mar 30, 2026 | Bolton StephaniePresident, Global Epilepsy | Option exercise | 17,815 | — | Form 4 |
| Mar 30, 2026 | Makatsaria VladimirChief Executive Officer | Tax withholding | 11,159 | $683.71K | Form 4 |
| Mar 30, 2026 | Makatsaria VladimirChief Executive Officer | Option exercise | 21,042 | — | Form 4 |
| Mar 30, 2026 | Shvartsburg AlexChief Financial Officer | Tax withholding | 12,868 | $788.42K | Form 4 |
| Mar 30, 2026 | Shvartsburg AlexChief Financial Officer | Option exercise | 30,835 | — | Form 4 |
| Mar 30, 2026 | Poletti FrancoPresident, Cardiopulmonary | Tax withholding | 1,370 | $83.94K | Form 4 |
| Mar 30, 2026 | Poletti FrancoPresident, Cardiopulmonary | Option exercise | 3,184 | — | Form 4 |
| Mar 30, 2026 | Tezel AhmetChief Innovation Officer | Tax withholding | 1,186 | $72.67K | Form 4 |
| Mar 30, 2026 | Tezel AhmetChief Innovation Officer | Option exercise | 3,408 | — | Form 4 |
| Mar 11, 2026 | Poletti FrancoPresident, Cardiopulmonary | Tax withholding | 69 | $4.30K | Form 4 |
| Mar 11, 2026 | Poletti FrancoPresident, Cardiopulmonary | Tax withholding | 1,980 | $123.27K | Form 4 |
| Mar 11, 2026 | Poletti FrancoPresident, Cardiopulmonary | Option exercise | 2,140 | $123.26K | Form 4 |
| Dec 15, 2025 | Hutchinson Michael DamonSVP, CLO and Company Secretary | Tax withholding | 1,122 | $70.75K | Form 4 |
| Dec 15, 2025 | Hutchinson Michael DamonSVP, CLO and Company Secretary | Option exercise | 2,254 | — | Form 4 |
| Dec 15, 2025 | PODLOGAR SUSAN MDirector | Tax withholding | 269 | $16.96K | Form 4 |
| Dec 15, 2025 | PODLOGAR SUSAN MDirector | Option exercise | 2,355 | — | Form 4 |
| Dec 15, 2025 | Poletti FrancoPresident, Cardiopulmonary | Tax withholding | 416 | $26.23K | Form 4 |
| Dec 15, 2025 | Poletti FrancoPresident, Cardiopulmonary | Option exercise | 967 | — | Form 4 |
| Nov 18, 2025 | Story BrookeDirector | Sale | 250 | $13.48K | Form 4 |
| Sep 15, 2025 | Poletti FrancoPresident, Cardiopulmonary | Tax withholding | 277 | $15.35K | Form 4 |
| Sep 15, 2025 | Poletti FrancoPresident, Cardiopulmonary | Option exercise | 643 | — | Form 4 |
| Aug 25, 2025 | Bianchi FrancescoDirector | Sale | 1,500 | $84.75K | Form 4 |
| Jun 15, 2025 | Tezel AhmetChief Innovation Officer | Tax withholding | 1,032 | $47.22K | Form 4 |
| Jun 15, 2025 | Tezel AhmetChief Innovation Officer | Option exercise | 2,967 | — | Form 4 |
| Jun 15, 2025 | WILVER PETER MDirector | Tax withholding | 410 | $18.76K | Form 4 |
| Jun 15, 2025 | WILVER PETER MDirector | Option exercise | 3,416 | — | Form 4 |
| Jun 15, 2025 | Enxing Seng StacyDirector | Tax withholding | 410 | $18.76K | Form 4 |
| Jun 15, 2025 | Enxing Seng StacyDirector | Option exercise | 3,416 | — | Form 4 |
| Jun 15, 2025 | Story BrookeDirector | Tax withholding | 410 | $18.76K | Form 4 |
| Jun 15, 2025 | Story BrookeDirector | Option exercise | 3,416 | — | Form 4 |
| Jun 15, 2025 | SCHERMERHORN TODD CDirector | Tax withholding | 410 | $18.76K | Form 4 |
| Jun 15, 2025 | SCHERMERHORN TODD CDirector | Option exercise | 3,416 | — | Form 4 |
| Jun 15, 2025 | Bianchi FrancescoDirector | Tax withholding | 410 | $18.76K | Form 4 |
| Jun 15, 2025 | Bianchi FrancescoDirector | Option exercise | 3,416 | — | Form 4 |
| Jun 15, 2025 | O'Kane SharonDirector | Tax withholding | 1,606 | $73.49K | Form 4 |
| Jun 15, 2025 | O'Kane SharonDirector | Option exercise | 3,416 | — | Form 4 |
| Jun 15, 2025 | Barry James ChristopherDirector | Tax withholding | 410 | $18.76K | Form 4 |
| Jun 15, 2025 | Barry James ChristopherDirector | Option exercise | 3,416 | — | Form 4 |
| Jun 15, 2025 | KOZY WILLIAM ADirector | Tax withholding | 581 | $26.59K | Form 4 |
| Jun 15, 2025 | KOZY WILLIAM ADirector | Option exercise | 4,840 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4